Our Story
We’re Engineering the Future of Medical Imaging One Breakthrough at a Time.
Founded on the belief that better imaging leads to better outcomes, Perfusio has evolved from a hardware-based imaging company into a leading provider of AI-driven software solutions for perfusion visualization. Our patented MSPV technology is helping clinicians make faster, more informed decisions.
Who We Serve
Perfusio is actively seeking research institutions, device manufacturers, and military collaborators to advance LSCI-based burn triage.
Clinicians: Help us validate across diverse wound types and populations.
OEMs: Integrate our platform into your own diagnostic or surgical tools.
DoD & Emergency Planners: Collaborate on ruggedization and field deployment strategies.
-
Burn surgeons and burn unit staff need rapid, quantitative insights. Perfusio supports critical decisions like surgical timing and debridement planning without relying on subjective visual cues.
-
In chaotic trauma bays or ER settings, Perfusio delivers instant, contact-free imaging. No gels. No prep. Just fast insight for faster action.
-
Children can't always stay still or tolerate traditional diagnostic methods. Perfusio enables gentle, accurate burn assessment in seconds. Ideal for young or anxious patients.
-
Perfusio equips medics with battlefield-grade diagnostics. It’s miniaturized, rugged, and designed for use without specialty training or ideal lighting.
-
Perfusio reduces diagnostic variability and speeds up the right interventions. It’s a smart investment in quality care and resource optimization.
Dual-Use by Design
Perfusio Bridges Military and Civilian Medicine
Our platform is built for:
Prolonged field care and battlefield triage.
High-volume trauma centers and regional burn units.
Telemedicine programs and rural ERs lacking specialty coverage.
Backed by FDA-cleared CERTES™ technology, we’ve miniaturized and adapted our platform to meet the needs of both front-line medics and world-class clinicians.
Our Leadership
We’re bringing breakthrough medical imaging to market, powered by a leadership team that blends business acumen with scientific vision.
Phil Hodges
Chief Executive Officer
Peter Geiger
Chief Financial Officer
Dr. Cheng Chen
Chief Science and Technical Officer Co-Founder
Joffre Alvarez
Director of Operations
Board Of Directors
David LaVance
Chief Executive Officer, Surround Medical
Phil Hodges
Chief Executive Officer, Perfusio
David LaVance
Chief Executive Officer, Surround Medical
Rich Balot
Chief Executive Officer, Victra
George McGinn
Board Member, Healthcare Advisor
Bruce Ferguson
Co-founder, Perfusio
Mercedes K.C. Dullum,
MD, FACS, FACC
Healthcare Consultant
Steve Taylor
Board Member
Medical Advisory Board
Dr. Ashesh N. Buch,
MBChB, MD, FRCP, FSCAI
Attending Interventional Cardiologist
Chesapeake Regional Medical Center
Mark A. Farber,
MD FACS
Chief, Division of Vascular Surgery
Director, UNC Aortic Network
Professor of Surgery and Radiology
University of North Carolina
Chapel Hill, NC
David B. Leeser,
MD, MBA, FACS
Professor and Chief of Transplant Surgery and Immunology
East Carolina University, Brody School of Medicine
Chief of Transplantation, Vidant Medical Center
John M. Prager,
PhD
Instructor, Duke Continuing Studies
Duke University
Thomas J Watson Center, IBM (Retired)

Patents & Clinical Validation
Innovation is not just part of our story. It is protected by it.
Perfusio holds 17 issued patents, with more than 20 additional applications pending. Our intellectual property portfolio reflects over a decade of development in advanced imaging, laser technology, and AI-powered diagnostics.
-
Patents
8 National, 9 International Patents
(20+ under review)2016: 1st, 2nd
2018: 3rd
2019: 4th, 5th
2020: 6th, 7th, 8th, 9th, 10th
2021: 11th, 12th, 13th, 14th, 15th
2022: 16th, 17th
The technology behind Perfusio was originally developed at East Carolina University by a cross-disciplinary team of surgeons, physicists, and engineers. Today, we continue to collaborate with ECU to expand the platform across a wide range of clinical applications.
Our most recent patent, titled Multi-Spectral Laser Imaging (MSLI) Methods and Systems for Blood Flow and Perfusion Imaging and Quantification, represents the foundation of our global intellectual property protection strategy. It reinforces the core capabilities of the Perfusio platform and secures our position as a leader in real-time tissue imaging.
This is more than invention. It is validation, supported by peer-reviewed research, federal grants, and a commitment to improve patient care through precision imaging.